ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 906,58
-0,27%
Dow Jones
44 713,58
0,65%
DAX
21 282,18
-0,48%
Brent Oil
76,145
-1,35%
Bitcoin
101 236,36
-3,28%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE

  6. Molecular Partners Ag (0QXX) Cours

Molecular Partners Ag

Molecular Partners Ag (0QXX)

LSE
25,20
0,00
(0,00%)
Fermé 27 Janvier 5:30PM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
25,20
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
25,20 Plage de 52 semaines 25,20
Cap du marché
916,121M
Clôture Veille
25,20
Ouverture
-
Dernière Transaction
(O)
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
540
Actions en circulation
36 354 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,91
Bénéfice par action (BPA)
-1,71
Chiffre d'affairess
7,04M
Bénéfice net
-61,98M

À propos de Molecular Partners Ag

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.molecularpartners.com
Siège social
Schlieren, Che
Fondé
-
Molecular Partners Ag est coté dans le secteur Pharmaceutical Preparations de la London Stock Exchange avec le ticker 0QXX. Le dernier cours de clôture d'Molecular Partners était de CHF25,20. Au cours de la dernière année, les actions de Molecular Partners ont été négociées dans une fourchette de prix de CHF 25,20 à CHF 25,20.

Molecular Partners compte actuellement 36 354 000 actions en circulation. La capitalisation boursière d'Molecular Partners est de CHF916,12 million. Molecular Partners a un ratio cours/bénéfice (ratio PE) de -2.91.

0QXX Dernières nouvelles

Plus de nouvelles

Molecular Partners Outlines Clinical Expansion Plans and Strengthens Radiopharma Strategic Focus for 2025 at 43rd Annual J.P. Morgan Healthcare Conference

Molecular Partners Outlines Clinical Expansion Plans and Strengthens Radiopharma Strategic Focus for 2025 at 43rd Annual J.P. Morgan Healthcare Conference Radio-DARPin MP0712 against DLL3, in...

12 Janvier 2025
UK Regulatory

Molecular Partners and Orano Med expand partnership to develop Targeted Alpha Radio-Therapies for cancer

Molecular Partners and Orano Med expand partnership to develop Targeted Alpha Radio-Therapies for cancer New agreement enables both companies to fuel a broad and innovative pipeline of...

12 Janvier 2025
UK Regulatory

Molecular Partners to Present at JP Morgan Healthcare Conference and Baader Helvea Swiss Equities Conference in January

Molecular Partners to Present at JP Morgan Healthcare Conference and Baader Helvea Swiss Equities Conference in January ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Dec. 17, 2024 (GLOBE...

17 Décembre 2024
UK Regulatory

Molecular Partners Presents Clinical Data Supporting its Ongoing MP0533 Study and Preclinical Data on Next-Gen Conditioning Agent MP0621 at ASH 2024

Molecular Partners Presents Clinical Data Supporting its Ongoing MP0533 Study and Preclinical Data on Next-Gen Conditioning Agent MP0621 at ASH 2024 MP0533 phase 1/2a dose escalation study...

08 Décembre 2024
UK Regulatory

Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024

Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024 Preclinical proof-of-concept data supports the...

07 Novembre 2024
UK Regulatory

Molecular Partners Announces Upcoming Poster Presentations at the 65th ASH Annual Meeting and Exposition

Molecular Partners Announces Upcoming Poster Presentations at the 65th ASH Annual Meeting and Exposition Clinical update from ongoing MP0533 phase 1/2a dose escalation study confirms overall...

05 Novembre 2024
UK Regulatory

Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-going

Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-going Radio-DARPin Therapy...

31 Octobre 2024
UK Regulatory

Molecular Partners Announces Pricing of $20 Million Underwritten Offering

Molecular Partners Announces Pricing of $20 Million Underwritten Offering ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art...

25 Octobre 2024
UK Regulatory

Molecular Partners and Orano Med Strengthen Agreement to Co-Develop 212Pb-Based Radio-DARPin Therapeutics

Molecular Partners and Orano Med Strengthen Agreement to Co-Develop 212Pb-Based Radio-DARPin Therapeutics Under the revised agreement, both companies will co-develop four Radio-DARPin programs;...

22 Octobre 2024
UK Regulatory

Molecular Partners and Orano Med Present Additional Positive Preclinical Data Supporting DLL3 Targeting Radio-DARPin Therapeutic Candidate MP0712 at EANM 2024

Molecular Partners and Orano Med Present Additional Positive Preclinical Data Supporting DLL3 Targeting Radio-DARPin Therapeutic Candidate MP0712 at EANM 2024 Dose-dependent efficacy observed with...

22 Octobre 2024
UK Regulatory
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10025.225.225.26225.2DE
40025.225.225.246625.2DE
120025.225.225.254025.2DE
260025.225.225.239525.2DE
520025.225.225.235825.2DE
1560025.225.225.2948325.2DE
2600025.225.225.2723025.2DE

0QXX - Frequently Asked Questions (FAQ)

What is the current Molecular Partners share price?
The current share price of Molecular Partners is CHF 25,20
How many Molecular Partners shares are in issue?
Molecular Partners has 36 354 000 shares in issue
What is the market cap of Molecular Partners?
The market capitalisation of Molecular Partners is CHF 916,12M
What is the 1 year trading range for Molecular Partners share price?
Molecular Partners has traded in the range of CHF 25,20 to CHF 25,20 during the past year
What is the PE ratio of Molecular Partners?
The price to earnings ratio of Molecular Partners is -2,91
What is the cash to sales ratio of Molecular Partners?
The cash to sales ratio of Molecular Partners is 25,67
What is the reporting currency for Molecular Partners?
Molecular Partners reports financial results in CHF
What is the latest annual turnover for Molecular Partners?
The latest annual turnover of Molecular Partners is CHF 7,04M
What is the latest annual profit for Molecular Partners?
The latest annual profit of Molecular Partners is CHF -61,98M
What is the registered address of Molecular Partners?
The registered address for Molecular Partners is WAGISTRASSE 14, SCHLIEREN, 8952
What is the Molecular Partners website address?
The website address for Molecular Partners is www.molecularpartners.com
Which industry sector does Molecular Partners operate in?
Molecular Partners operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
NFXNuformix Plc
0,115p
(84,00%)
169,13M
CHFChesterfield Resources Plc
0,40p
(32,45%)
276,93k
IMMImmupharma Plc
5,20p
(28,40%)
49,53M
SNGSynairgen Plc
2,70p
(24,14%)
2,31M
GOODGood Energy Group Plc
480,00p
(21,52%)
902,4k
DARDar Global Plc
US$ 6,00
(-22,83%)
6,98k
CLAICel Ai Plc
0,345p
(-21,59%)
28,34M
CTAICatenai Plc
0,21p
(-17,65%)
87,41M
GENIGenincode Plc
4,00p
(-16,67%)
1,44M
WBIWoodbois Limited
0,095p
(-15,56%)
222,83M
UKOGUk Oil & Gas Plc
0,0205p
(-4,65%)
802,36M
CLONClontarf Energy Plc
0,045p
(12,50%)
689,68M
SYMESupply@me Capital Plc
0,0025p
(-13,79%)
415,74M
TRPTower Resources Plc
0,0295p
(0,00%)
411,68M
NTVONativo Resources Plc
0,0021p
(0,00%)
324,32M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

LSE
0QXX
Molecular Partners
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés